Impact of the COVID-19 pandemic on psychotropic prescribing: a systematic review
Objectives The global prevalence of mental health disorders has risen significantly since the beginning of the COVID-19 pandemic. The pandemic has additionally caused disruption to mental health services, leading to a shift from in-person to remote service delivery. Given its long-term impact, it ha...
Saved in:
Main Authors: | Nikolaos Mastellos, Marie line El Asmar, Kanika I Dharmayat, Antonio J Vallejo-Vaz, Ryan Irwin, Swettha Mahesarajah |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-09-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/14/9/e076791.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Impact of the COVID-19 pandemic on psychotropic prescribing: a systematic review
Published: (2025-01-01) -
Weight Gain, Obesity, and Psychotropic Prescribing
by: Nikhil Nihalani, et al.
Published: (2011-01-01) -
Changes over a decade in psychotropic prescribing for people with intellectual disabilities: prospective cohort study
by: Paula McSkimming, et al.
Published: (2020-09-01) -
Psychotropic drugs and bone
by: R.W. Gasser, et al.
Published: (2024-12-01) -
The Neuroprotective Disease-Modifying Potential of Psychotropics in Parkinson's Disease
by: Edward C. Lauterbach, et al.
Published: (2012-01-01)